In a previous study, we utilised ‘CARaMEL’ dual‐specific T cells, expressing a CAR specific for Her2 tumour antigen, and a T‐cell receptor (TCR) specific for a strong, tumour‐unrelated immunogen, the melanocyte protein gp100 (also known as pMEL). Here, PMEL is linked to neoplasm.